Monographie - Cefiderocol sulfate tosylate

Poslední aktualizace :
19/11/2024

Cefiderocol sulfate tosylate

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fetcroja

Didžioji Britanija, Ispanija, Italija, Meksikas, Prancūzija, Suomija, Švedija, Vokietija

Bibliografija : Cefiderocol sulfate tosylate

	tipas	leidinys
2093	Laboratorija	Cefiderocol (Fetcroja®)- Summary of Product Characteristics Shionogi B.V. 2020
4528	Žurnalas	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4634	Žurnalas	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4801	Žurnalas	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales